Update LICENSE (#9)
Browse files- Update LICENSE (905dbe5df38308ad25945764a2f27487fa79bd79)
Co-authored-by: Lakshmanan Arumugam <recursionaut@users.noreply.huggingface.co>
LICENSE
CHANGED
@@ -1,399 +1,362 @@
|
|
1 |
-
|
2 |
-
|
3 |
-
|
4 |
-
|
5 |
-
|
6 |
-
|
7 |
-
|
8 |
-
|
9 |
-
|
10 |
-
|
11 |
-
|
12 |
-
|
13 |
-
|
14 |
-
|
15 |
-
|
16 |
-
|
17 |
-
|
18 |
-
|
19 |
-
|
20 |
-
and
|
21 |
-
|
22 |
-
|
23 |
-
|
24 |
-
|
25 |
-
|
26 |
-
|
27 |
-
|
28 |
-
|
29 |
-
|
30 |
-
|
31 |
-
|
32 |
-
|
33 |
-
|
34 |
-
|
35 |
-
|
36 |
-
|
37 |
-
|
38 |
-
|
39 |
-
|
40 |
-
|
41 |
-
|
42 |
-
|
43 |
-
|
44 |
-
|
45 |
-
|
46 |
-
|
47 |
-
|
48 |
-
|
49 |
-
|
50 |
-
|
51 |
-
|
52 |
-
|
53 |
-
|
54 |
-
|
55 |
-
|
56 |
-
|
57 |
-
|
58 |
-
|
59 |
-
|
60 |
-
|
61 |
-
|
62 |
-
|
63 |
-
|
64 |
-
|
65 |
-
|
66 |
-
|
67 |
-
|
68 |
-
|
69 |
-
|
70 |
-
|
71 |
-
|
72 |
-
|
73 |
-
|
74 |
-
|
75 |
-
|
76 |
-
|
77 |
-
|
78 |
-
|
79 |
-
|
80 |
-
|
81 |
-
|
82 |
-
|
83 |
-
|
84 |
-
|
85 |
-
|
86 |
-
|
87 |
-
|
88 |
-
|
89 |
-
|
90 |
-
|
91 |
-
|
92 |
-
|
93 |
-
|
94 |
-
|
95 |
-
|
96 |
-
|
97 |
-
|
98 |
-
|
99 |
-
|
100 |
-
|
101 |
-
|
102 |
-
|
103 |
-
|
104 |
-
|
105 |
-
|
106 |
-
|
107 |
-
|
108 |
-
|
109 |
-
|
110 |
-
|
111 |
-
|
112 |
-
|
113 |
-
|
114 |
-
|
115 |
-
|
116 |
-
|
117 |
-
|
118 |
-
|
119 |
-
|
120 |
-
|
121 |
-
|
122 |
-
|
123 |
-
|
124 |
-
|
125 |
-
|
126 |
-
|
127 |
-
|
128 |
-
|
129 |
-
|
130 |
-
|
131 |
-
|
132 |
-
|
133 |
-
|
134 |
-
|
135 |
-
|
136 |
-
|
137 |
-
|
138 |
-
|
139 |
-
|
140 |
-
|
141 |
-
|
142 |
-
|
143 |
-
|
144 |
-
|
145 |
-
|
146 |
-
|
147 |
-
|
148 |
-
|
149 |
-
|
150 |
-
|
151 |
-
|
152 |
-
|
153 |
-
|
154 |
-
|
155 |
-
|
156 |
-
|
157 |
-
|
158 |
-
|
159 |
-
|
160 |
-
|
161 |
-
|
162 |
-
|
163 |
-
|
164 |
-
|
165 |
-
|
166 |
-
|
167 |
-
|
168 |
-
|
169 |
-
|
170 |
-
|
171 |
-
|
172 |
-
|
173 |
-
|
174 |
-
|
175 |
-
|
176 |
-
|
177 |
-
|
178 |
-
|
179 |
-
|
180 |
-
|
181 |
-
|
182 |
-
|
183 |
-
|
184 |
-
|
185 |
-
|
186 |
-
|
187 |
-
|
188 |
-
|
189 |
-
|
190 |
-
|
191 |
-
|
192 |
-
|
193 |
-
|
194 |
-
|
195 |
-
|
196 |
-
|
197 |
-
|
198 |
-
|
199 |
-
|
200 |
-
|
201 |
-
|
202 |
-
|
203 |
-
|
204 |
-
|
205 |
-
|
206 |
-
|
207 |
-
|
208 |
-
|
209 |
-
|
210 |
-
|
211 |
-
|
212 |
-
|
213 |
-
|
214 |
-
|
215 |
-
|
216 |
-
|
217 |
-
|
218 |
-
|
219 |
-
|
220 |
-
|
221 |
-
|
222 |
-
|
223 |
-
|
224 |
-
|
225 |
-
|
226 |
-
|
227 |
-
|
228 |
-
|
229 |
-
|
230 |
-
|
231 |
-
|
232 |
-
|
233 |
-
|
234 |
-
|
235 |
-
|
236 |
-
|
237 |
-
|
238 |
-
|
239 |
-
|
240 |
-
|
241 |
-
|
242 |
-
|
243 |
-
|
244 |
-
|
245 |
-
|
246 |
-
|
247 |
-
|
248 |
-
|
249 |
-
|
250 |
-
|
251 |
-
|
252 |
-
|
253 |
-
|
254 |
-
|
255 |
-
|
256 |
-
|
257 |
-
|
258 |
-
|
259 |
-
|
260 |
-
|
261 |
-
|
262 |
-
|
263 |
-
|
264 |
-
|
265 |
-
|
266 |
-
|
267 |
-
|
268 |
-
|
269 |
-
|
270 |
-
|
271 |
-
|
272 |
-
|
273 |
-
|
274 |
-
|
275 |
-
|
276 |
-
|
277 |
-
|
278 |
-
|
279 |
-
|
280 |
-
|
281 |
-
|
282 |
-
|
283 |
-
|
284 |
-
|
285 |
-
|
286 |
-
|
287 |
-
|
288 |
-
|
289 |
-
|
290 |
-
|
291 |
-
|
292 |
-
|
293 |
-
|
294 |
-
|
295 |
-
|
296 |
-
|
297 |
-
|
298 |
-
|
299 |
-
|
300 |
-
|
301 |
-
|
302 |
-
|
303 |
-
|
304 |
-
|
305 |
-
|
306 |
-
|
307 |
-
|
308 |
-
|
309 |
-
|
310 |
-
|
311 |
-
|
312 |
-
|
313 |
-
|
314 |
-
|
315 |
-
|
316 |
-
|
317 |
-
|
318 |
-
|
319 |
-
|
320 |
-
|
321 |
-
|
322 |
-
|
323 |
-
|
324 |
-
|
325 |
-
|
326 |
-
|
327 |
-
|
328 |
-
|
329 |
-
|
330 |
-
|
331 |
-
|
332 |
-
|
333 |
-
|
334 |
-
|
335 |
-
|
336 |
-
|
337 |
-
|
338 |
-
|
339 |
-
|
340 |
-
|
341 |
-
|
342 |
-
|
343 |
-
|
344 |
-
|
345 |
-
|
346 |
-
|
347 |
-
|
348 |
-
|
349 |
-
|
350 |
-
|
351 |
-
|
352 |
-
|
353 |
-
|
354 |
-
|
355 |
-
|
356 |
-
|
357 |
-
|
358 |
-
|
359 |
-
|
360 |
-
|
361 |
-
|
362 |
-
|
363 |
-
|
364 |
-
b. To the extent possible, if any provision of this Public License is
|
365 |
-
deemed unenforceable, it shall be automatically reformed to the
|
366 |
-
minimum extent necessary to make it enforceable. If the provision
|
367 |
-
cannot be reformed, it shall be severed from this Public License
|
368 |
-
without affecting the enforceability of the remaining terms and
|
369 |
-
conditions.
|
370 |
-
|
371 |
-
c. No term or condition of this Public License will be waived and no
|
372 |
-
failure to comply consented to unless expressly agreed to by the
|
373 |
-
Licensor.
|
374 |
-
|
375 |
-
d. Nothing in this Public License constitutes or may be interpreted
|
376 |
-
as a limitation upon, or waiver of, any privileges and immunities
|
377 |
-
that apply to the Licensor or You, including from the legal
|
378 |
-
processes of any jurisdiction or authority.
|
379 |
-
|
380 |
-
=======================================================================
|
381 |
-
|
382 |
-
Creative Commons is not a party to its public
|
383 |
-
licenses. Notwithstanding, Creative Commons may elect to apply one of
|
384 |
-
its public licenses to material it publishes and in those instances
|
385 |
-
will be considered the “Licensor.” The text of the Creative Commons
|
386 |
-
public licenses is dedicated to the public domain under the CC0 Public
|
387 |
-
Domain Dedication. Except for the limited purpose of indicating that
|
388 |
-
material is shared under a Creative Commons public license or as
|
389 |
-
otherwise permitted by the Creative Commons policies published at
|
390 |
-
creativecommons.org/policies, Creative Commons does not authorize the
|
391 |
-
use of the trademark "Creative Commons" or any other trademark or logo
|
392 |
-
of Creative Commons without its prior written consent including,
|
393 |
-
without limitation, in connection with any unauthorized modifications
|
394 |
-
to any of its public licenses or any other arrangements,
|
395 |
-
understandings, or agreements concerning use of licensed material. For
|
396 |
-
the avoidance of doubt, this paragraph does not form part of the
|
397 |
-
public licenses.
|
398 |
-
|
399 |
-
Creative Commons may be contacted at creativecommons.org.
|
|
|
1 |
+
CONFIDENTIAL
|
2 |
+
|
3 |
+
|
4 |
+
Recursion Pharmaceuticals, Inc.
|
5 |
+
Non-Commercial End User License Agreement
|
6 |
+
|
7 |
+
|
8 |
+
1. INTRODUCTION.
|
9 |
+
This Non-Commercial End User License Agreement (as may be revised from time to time, this
|
10 |
+
“Agreement”) is a binding agreement between You (as defined below) and Recursion Pharmaceuticals,
|
11 |
+
Inc., a Delaware corporation with offices located at 41 S. Rio Grande St., Salt Lake City, UT 84101 (“We,”
|
12 |
+
“Us,” or “Our”). This Agreement grants You a license to Use (as defined below) certain Licensed
|
13 |
+
Materials (as defined below) subject to Your acceptance of all terms contained in this Agreement. While
|
14 |
+
this Agreement is not a Creative Commons license, it incorporates certain core principles thereof,
|
15 |
+
including attribution, non-commercial, and ShareAlike (similar to CC BY-NC-SA).
|
16 |
+
Please read the terms of this Agreement carefully before Using any of the Licensed Materials. By
|
17 |
+
Using any of the Licensed Materials or by clicking to accept or agree to the terms of this Agreement, You
|
18 |
+
agree that You have read and understand the terms of this Agreement, and further agree to accept and
|
19 |
+
agree to comply with the terms of this Agreement. You represent that You are at least 18 years of age,
|
20 |
+
and if You are accessing or using the Licensed Materials on behalf of an entity, that You have the legal
|
21 |
+
authority to enter into this Agreement on that entity’s behalf. If You do not agree to the terms of this
|
22 |
+
Agreement, then You must not Use any Licensed Materials and You should click to reject or not agree to
|
23 |
+
the terms of this Agreement.
|
24 |
+
We may revise this Agreement from time to time, for any reason. Any change to this Agreement
|
25 |
+
will be effective immediately upon posting unless We state otherwise. You should check this Agreement
|
26 |
+
on the Site regularly. Your continued Use of the Licensed Materials after any changes to this Agreement
|
27 |
+
constitutes Your binding acceptance of this Agreement as revised, including such changes.
|
28 |
+
2. DEFINITIONS.
|
29 |
+
“Derivative Technology” means any product or technology generated, conceived, developed, or
|
30 |
+
reduced to practice through Your Use of, or derived from or based on, any Licensed Material. For clarity,
|
31 |
+
“Derivative Technology” includes any modified Recursion Dataset.
|
32 |
+
“Intellectual Property Rights” means all intellectual property and proprietary rights of any kind,
|
33 |
+
however denominated, throughout the world, including all rights in patents, patent applications,
|
34 |
+
copyrights, trademarks, trade secrets, designs, inventions, works of authorship, software (including
|
35 |
+
source code and object code), documentation, know-how, methods, processes, algorithms, data and
|
36 |
+
databases, and all updates, upgrades, new versions, and enhancements of any and all of the foregoing,
|
37 |
+
and all registrations and applications for any and all of the foregoing.
|
38 |
+
“Licensed Intellectual Property Rights” means copyrights and similar rights closely related to
|
39 |
+
copyrights, including rights in software, data, and databases, (a) owned or otherwise controlled by Us
|
40 |
+
and (b) necessary for You to exercise Your rights under, and in strict accordance with the terms of, this
|
41 |
+
Agreement. “Licensed Intellectual Property Rights” does not include any other Intellectual Property
|
42 |
+
Rights, including patent rights, trademark rights, moral rights, or publicity, privacy, or other similar
|
43 |
+
personality rights.
|
44 |
+
“Licensed Materials” means the Recursion Software and/or Recursion Dataset, as applicable, to
|
45 |
+
which We apply this Agreement. For clarity, references to the “Licensed Materials” in this Agreement
|
46 |
+
include any portion thereof.
|
47 |
+
|
48 |
+
|
49 |
+
|
50 |
+
“Permitted Purpose” means non-commercial research, academic, and educational purposes
|
51 |
+
only. For the purposes of this definition, “non-commercial research” means research not primarily
|
52 |
+
intended for or directed towards commercial advantage or monetary compensation.
|
53 |
+
“Recursion Dataset” means the data and datasets (which may include, without limitation,
|
54 |
+
phenomics maps, images, image data, embeddings, genetic information, and other metadata), in each
|
55 |
+
case, made available to You through the Site, including through or otherwise in connection with the
|
56 |
+
Recursion Software, but excluding, for clarity, the RxRx19x dataset.
|
57 |
+
“Recursion Software” means Recursion’s proprietary software (including, without limitation,
|
58 |
+
Recursion’s proprietary AI Models) made available to You through the Site, including any updates or
|
59 |
+
upgrades thereto and any written documentation or other media related thereto made available to You
|
60 |
+
through the Site, which may include, without limitation, the MolRec™ application. The Recursion
|
61 |
+
Software will not be provided in source code format.
|
62 |
+
“Site” means www.rxrx.ai, together with its subdomains.
|
63 |
+
“Use” (and its correlatives) means (a) use, download, and access, and (b) solely with respect to
|
64 |
+
the Recursion Dataset, copy, analyze, modify, adapt, aggregate, share, and use to produce Derivative
|
65 |
+
Technology.
|
66 |
+
“You” (and its correlatives) means the individual(s) or entity(ies) that Use the Licensed Materials
|
67 |
+
under this Agreement. If you are Using the Licensed Materials in your individual capacity, all references
|
68 |
+
to “You” reference you as an individual person. If you are Using the Licensed Materials on behalf of a
|
69 |
+
company or other entity, all references to “You” reference both you as an individual person and that
|
70 |
+
company or entity.
|
71 |
+
3. LICENSE GRANT.
|
72 |
+
Subject to Your compliance with the terms of this Agreement, We grant to You a personal,
|
73 |
+
limited, non-exclusive, non-transferable, non-sublicensable, royalty-free, irrevocable (except as set forth
|
74 |
+
below) license under the Licensed Intellectual Property Rights to Use the Licensed Materials solely for
|
75 |
+
the Permitted Purpose.
|
76 |
+
For clarity, and without limiting the generality of the foregoing, You may not, in any and all fields:
|
77 |
+
(a) sell, lease, rent, lend, license, sublicense, assign, distribute, share, publish, transfer, or
|
78 |
+
otherwise make available the Licensed Materials or Derivative Technology to any individual or entity for
|
79 |
+
monetary compensation;
|
80 |
+
(b) Use the Licensed Materials or Derivative Technology, in each case, to initiate or conduct,
|
81 |
+
either for Yourself, Your affiliates, or a third party, a program directed to the research, development,
|
82 |
+
manufacture, commercialization, or exploitation of any product (including any pharmaceutical, biologic,
|
83 |
+
or diagnostic product) or service that is, or if successful ultimately would be, intended for commercial
|
84 |
+
sale, distribution, or offering, including validating a biological target in connection with the foregoing
|
85 |
+
activities (collectively, a “Commercial Program”);
|
86 |
+
(c) Use the Licensed Materials or Derivative Technology, in each case, to directly or
|
87 |
+
indirectly research, develop, commercialize, or exploit any software, model, algorithm, platform, or
|
88 |
+
artificial intelligence (collectively, “AI Models”) that is, or if successful ultimately would be, intended for
|
89 |
+
commercial sale, distribution, or offering;
|
90 |
+
|
91 |
+
|
92 |
+
|
93 |
+
|
94 |
+
|
95 |
+
(d) deploy any AI Model trained on the Licensed Materials or Derivative Technology, in each
|
96 |
+
case, for the purpose of initiating or conducting, either for Yourself, Your affiliates, or a third party, any
|
97 |
+
Commercial Program;
|
98 |
+
(e) Use the Licensed Materials or Derivative Technology (including any AI Model trained on
|
99 |
+
Licensed Materials), in each case, for the sale, offer for sale, or performance of commercial services;
|
100 |
+
(f) engage in, or advise in the engaging of, any trading of securities using or based on the
|
101 |
+
Licensed Materials or Derivative Technology; or
|
102 |
+
(g) publish any article or other document, or deliver any presentation for monetary
|
103 |
+
compensation that is based on Your Use of the Licensed Materials or Derivative Technology (for clarity,
|
104 |
+
this sub-clause (g) will not prohibit You from publishing or presenting any article, document, or
|
105 |
+
presentation that You author or present Yourself in any medium or format so long as You do not directly
|
106 |
+
or indirectly receive any monetary compensation for such publication or presentation).
|
107 |
+
If You wish to Use the Licensed Materials or Derivative Technology for any purpose not permitted
|
108 |
+
by this Agreement, please contact Us to discuss such Use – a commercial license may be available. Any
|
109 |
+
such commercial Use by You (to the extent approved by Us) will be subject to separate commercial
|
110 |
+
licensing terms, and We will retain sole discretion whether or not to agree to any such Use and grant
|
111 |
+
such license (including the applicable terms thereof).
|
112 |
+
4. ATTRIBUTION REQUIREMENTS.
|
113 |
+
You must include an attribution to Us in the applicable form set forth below when citing any
|
114 |
+
Recursion Dataset or any Recursion Software constituting an AI Model:
|
115 |
+
For any Recursion Dataset: “We used the [insert the name of the dataset (e.g., RxRx3)] dataset,
|
116 |
+
available from Recursion Pharmaceuticals at www.rxrx.ai, pursuant to Recursion
|
117 |
+
Pharmaceutical’s licensing terms at [insert hyperlink to this Agreement]. Under this license,
|
118 |
+
Recursion Pharmaceuticals disclaims all representations and warranties with respect to such
|
119 |
+
dataset.”
|
120 |
+
For any Recursion Software constituting an AI Model: “We used the [insert the name of AI
|
121 |
+
Model] AI model, available from Recursion Pharmaceuticals at www.rxrx.ai, pursuant to
|
122 |
+
Recursion Pharmaceutical’s licensing terms at [insert hyperlink to this Agreement]. Under this
|
123 |
+
license, Recursion Pharmaceuticals disclaims all representations and warranties with respect to
|
124 |
+
such AI model.”
|
125 |
+
You should insert the information specified in brackets above, and delete such brackets, when including
|
126 |
+
such attribution.
|
127 |
+
In addition, You must indicate whether You modified the applicable Licensed Material, or
|
128 |
+
otherwise used any Licensed Material to create any Derivative Technology, and if so, indicate that such
|
129 |
+
Derivative Technology was created using such Licensed Material, and retain any indication of the
|
130 |
+
foregoing previously made by other individuals or entities.
|
131 |
+
If We request, You must remove any of the information required above to the extent reasonably
|
132 |
+
practicable. Nothing in this Agreement constitutes or may be construed as permission to assert or imply
|
133 |
+
that You are, or that Your Use of the Licensed Materials or Derivative Technology is, connected with, or
|
134 |
+
sponsored, endorsed, or granted official status by, Us.
|
135 |
+
5. ACCEPTABLE USE TERMS
|
136 |
+
You will not, and will not permit or encourage any other individual or entity to:
|
137 |
+
|
138 |
+
|
139 |
+
|
140 |
+
(a) reverse engineer, disassemble, decompile, decode, adapt, or otherwise attempt to
|
141 |
+
derive, recreate, or gain access to the source code of the Recursion Software, in whole or in part;
|
142 |
+
(b) except as expressly permitted by Section 3 (License Grant), modify, adapt, or create
|
143 |
+
derivative works or improvements of the Licensed Materials;
|
144 |
+
(c) except as expressly permitted by Section 3 (License Grant), sell, lease, rent, lend, license,
|
145 |
+
sublicense, assign, distribute, share, publish, transfer, or otherwise make available the Licensed Materials
|
146 |
+
to any individual or entity;
|
147 |
+
(d) Use the Licensed Materials in any manner or for any purpose that infringes,
|
148 |
+
misappropriates, or otherwise violates any Intellectual Property Right of any individual or entity;
|
149 |
+
(e) remove, delete, alter, or obscure any trademarks or any copyright, trademark, patent, or
|
150 |
+
other Intellectual Property Right notices from the Licensed Materials, including any copy thereof;
|
151 |
+
(f) Use the Licensed Materials to violate any national or international law, statute, decree,
|
152 |
+
rule, or regulation;
|
153 |
+
(g) attempt to interfere with the proper working of the Recursion Software, or remove,
|
154 |
+
disable, circumvent, or otherwise create or implement any workaround to any security or technological
|
155 |
+
measures for the Licensed Materials, including any measures that control access to the Licensed
|
156 |
+
Materials;
|
157 |
+
(h) disrupt or interfere with the Recursion Software or Our systems, servers, or networks, or
|
158 |
+
fail to comply with any requirements, procedures, policies, or regulations of networks connected to the
|
159 |
+
Recursion Software, or transmit any viruses, worms, defects, Trojan horses, spyware, malware,
|
160 |
+
ransomware, or any items of a destructive nature through Your Use of the Recursion Software; or
|
161 |
+
(i) Use the Licensed Materials in any abusive or illegal way, as determined in Our sole
|
162 |
+
discretion.
|
163 |
+
6. INTELLECTUAL PROPERTY RIGHTS.
|
164 |
+
You acknowledge and agree that the Licensed Materials are provided under license, and not
|
165 |
+
sold, to You. You acknowledge and agree that the Licensed Intellectual Property Rights are proprietary to
|
166 |
+
Us, and the Licensed Materials are protected under copyright and other Intellectual Property Rights
|
167 |
+
owned or controlled by Us. We own and retain ownership of all Our Intellectual Property Rights,
|
168 |
+
including all rights, title, and interests in and to the Licensed Materials (including any portion thereof
|
169 |
+
that may be incorporated into any Derivative Technology). Under applicable law, Your separate
|
170 |
+
contribution to any Derivative Technology may be subject to Intellectual Property Rights owned or
|
171 |
+
controlled by You (“Arising Intellectual Property Rights”).
|
172 |
+
All rights not expressly granted to You herein are reserved for Us. Except for the limited license
|
173 |
+
granted to You herein, this Agreement does not grant You any ownership or other rights or interests in or
|
174 |
+
to the Licensed Materials or Licensed Intellectual Property Rights, whether by implication, estoppel, or
|
175 |
+
otherwise.
|
176 |
+
7. SHARING LICENSED MATERIALS.
|
177 |
+
Every individual or entity with whom You share the Recursion Dataset (including any portion of
|
178 |
+
the Recursion Dataset incorporated into any Derivative Technology) automatically receives an offer from
|
179 |
+
Us to Use such Recursion Dataset or portion thereof, as applicable, under the terms of this Agreement.
|
180 |
+
If You share any Derivative Technology with any individual(s) or entity(ies), then the license You
|
181 |
+
apply to Your Arising Intellectual Property Rights in such Derivative Technology must be essentially the
|
182 |
+
|
183 |
+
|
184 |
+
|
185 |
+
equivalent of this Agreement, and for the avoidance of doubt, must not permit any Use of such
|
186 |
+
Derivative Technology for any purpose other than a Permitted Purpose.
|
187 |
+
If You share any Recursion Dataset or Derivative Technology, You may not offer or impose on any
|
188 |
+
recipient of the Recursion Dataset or Derivative Technology any additional or different terms or
|
189 |
+
conditions, or apply any technological measures to, the recipient’s use of the Recursion Dataset or
|
190 |
+
Derivative Technology if doing so restricts such recipient from Using the Recursion Dataset or Derivative
|
191 |
+
Technology to the same extent as is permitted under this Agreement.
|
192 |
+
8. UPDATES.
|
193 |
+
We will have no obligation to provide upgrades or updates to the Licensed Materials. You
|
194 |
+
acknowledge that You may be required on a periodic or as-needed basis to apply updates to or
|
195 |
+
re-download and re-install the Recursion Software to address security, interoperability, or performance
|
196 |
+
issues, or to incorporate new features. You will promptly apply such updates to, or download and install,
|
197 |
+
as applicable, all such updates or upgrades, and acknowledge and agree that the Licensed Materials or
|
198 |
+
portions thereof may not properly operate should You fail to do so. We may also modify or delete in
|
199 |
+
their entirety certain features and functionality of the Licensed Materials, and You agree that We have
|
200 |
+
no obligation to continue to provide the Licensed Materials or enable any particular features or
|
201 |
+
functionality thereof.
|
202 |
+
9. THIRD-PARTY MATERIALS.
|
203 |
+
The Licensed Materials may display, include, or make available third-party content and
|
204 |
+
functionality (including data, information, applications, and other products, services, or materials), or
|
205 |
+
provide links to third-party websites or services (“Third-Party Materials”). You acknowledge and agree
|
206 |
+
that We are not responsible for Third-Party Materials, including their accuracy, completeness, timeliness,
|
207 |
+
validity, copyright compliance, legality, decency, quality, or any other aspect thereof. We do not assume
|
208 |
+
and will not have any liability or responsibility to You or any other individual or entity for any Third-Party
|
209 |
+
Materials. Third-Party Materials and links thereto are provided solely as a convenience to You, and You
|
210 |
+
will access and use them entirely at Your own risk and subject to such third party’s terms and conditions.
|
211 |
+
10. PRIVACY POLICY.
|
212 |
+
You acknowledge that when You Use any of the Licensed Materials, We may use automatic
|
213 |
+
means (including, for example, cookies and web beacons) to collect information about Your electronic
|
214 |
+
device and about Your use of the Licensed Materials. You also may be required to provide certain
|
215 |
+
information about Yourself as a condition to Using the Licensed Materials, or certain of their features or
|
216 |
+
functionality. All information We collect through or in connection with the Licensed Materials is subject
|
217 |
+
to Our Privacy Policy at https://www.recursion.com/privacy-notice (the “Privacy Policy”), which is
|
218 |
+
incorporated herein by reference. By Using the Licensed Materials, You consent to all actions taken by Us
|
219 |
+
with respect to Your information in compliance with the Privacy Policy.
|
220 |
+
11. TERM AND TERMINATION.
|
221 |
+
The term of this Agreement (“Term”) commences when You download the Recursion Software or
|
222 |
+
otherwise Use any Licensed Materials, and continues for the term of the Licensed Intellectual Property
|
223 |
+
Rights unless otherwise earlier terminated.
|
224 |
+
Your rights under this Agreement terminate automatically if You fail to comply with this
|
225 |
+
Agreement. Where Your right to Use the Licensed Materials has terminated as provided in the
|
226 |
+
immediately preceding sentence, Your right reinstates (a) automatically as of the date the violation is
|
227 |
+
cured, provided it is cured within 30 days of Your discovery of the violation, or (b) upon express
|
228 |
+
|
229 |
+
|
230 |
+
|
231 |
+
|
232 |
+
reinstatement by Us. However, this paragraph does not affect any right that We may have to seek
|
233 |
+
remedies for Your violation of this Agreement.
|
234 |
+
For the avoidance of doubt, We may also offer the Licensed Material under separate terms or
|
235 |
+
conditions, or stop distributing or making the Licensed Materials available at any time; however, doing so
|
236 |
+
will not terminate this Agreement.
|
237 |
+
Upon termination of this Agreement: (i) all licenses and other rights granted to You under this
|
238 |
+
Agreement will terminate; (ii) You will immediately cease all use of the Licensed Materials, and will
|
239 |
+
delete or otherwise destroy, at Your cost, all Licensed Materials (including, for clarity, all copies thereof),
|
240 |
+
provided that You may continue practicing Your Arising Intellectual Property Rights in any Derivative
|
241 |
+
Technology so long as You do not Use the Licensed Materials (including any portion thereof incorporated
|
242 |
+
into the Derivative Technology); and (iii) the provisions of this Agreement which by their nature must
|
243 |
+
survive termination of this Agreement will continue in force upon any termination, including, but not
|
244 |
+
limited to, Your obligations relating to Intellectual Property Rights, disclaimer of warranties, limitation of
|
245 |
+
liability, effects of termination, and the general provisions.
|
246 |
+
12. DISCLAIMER OF WARRANTIES.
|
247 |
+
THE LICENSED MATERIALS, INCLUDING ANY THIRD-PARTY MATERIALS PROVIDED THEREIN, ARE
|
248 |
+
BEING PROVIDED “AS IS,” WITH ALL FAULTS AND DEFECTS, AND WITHOUT REPRESENTATIONS OR
|
249 |
+
WARRANTIES OF ANY KIND. TO THE MAXIMUM EXTENT PERMITTED UNDER APPLICABLE LAW, WE, ON
|
250 |
+
OUR OWN BEHALF AND ON BEHALF OF OUR AFFILIATES AND OUR AND THEIR RESPECTIVE DIRECTORS,
|
251 |
+
OFFICERS, EMPLOYEES, PARTNERS, LICENSORS, AGENTS, SUCCESSORS, AND ASSIGNS, EXPRESSLY
|
252 |
+
DISCLAIM ALL REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY, OR
|
253 |
+
OTHERWISE, WITH RESPECT TO THE LICENSED MATERIALS, INCLUDING ALL IMPLIED WARRANTIES OF
|
254 |
+
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT, AND
|
255 |
+
WARRANTIES THAT MAY ARISE OUT OF COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE, OR
|
256 |
+
TRADE PRACTICE. WITHOUT LIMITATION TO THE FOREGOING, WE PROVIDE NO WARRANTY OR
|
257 |
+
UNDERTAKING, AND MAKE NO REPRESENTATION OF ANY KIND THAT THE LICENSED MATERIALS WILL
|
258 |
+
MEET YOUR REQUIREMENTS, ACHIEVE ANY INTENDED RESULTS, BE COMPATIBLE, OR WORK WITH ANY
|
259 |
+
OTHER SOFTWARE, APPLICATIONS, SYSTEMS, OR SERVICES, OPERATE WITHOUT INTERRUPTION, MEET
|
260 |
+
ANY PERFORMANCE OR RELIABILITY STANDARDS, OR BE ERROR-FREE, OR THAT ANY ERRORS OR DEFECTS
|
261 |
+
CAN OR WILL BE CORRECTED. WE DO NOT ENDORSE OR REPRESENT OR GUARANTEE THE
|
262 |
+
TRUTHFULNESS, ACCURACY, OR RELIABILITY OF ANY LICENSED MATERIALS. YOU ACCEPT THE ENTIRE
|
263 |
+
RISK OF THE ACCURACY, RELIABILITY, SECURITY, OR OTHER PERFORMANCE WITH RESPECT TO YOUR USE
|
264 |
+
OF THE LICENSED MATERIALS OR OTHER EXERCISE OF YOUR RIGHTS UNDER THIS AGREEMENT,
|
265 |
+
INCLUDING YOUR DEVELOPMENT OR USE OF ANY DERIVATIVE TECHNOLOGY. THIS DISCLAIMER OF
|
266 |
+
WARRANTIES WILL BE INTERPRETED IN A MANNER THAT, TO THE FULLEST EXTENT PERMITTED BY
|
267 |
+
APPLICABLE LAW, MOST CLOSELY APPROXIMATES AN ABSOLUTE DISCLAIMER OF WARRANTIES.
|
268 |
+
13. LIMITATION OF LIABILITY.
|
269 |
+
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT WILL WE OR ANY OF
|
270 |
+
OUR AFFILIATES, OR ANY OF OUR OR THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES, PARTNERS,
|
271 |
+
LICENSORS, AGENTS, SUCCESSORS, OR ASSIGNS, HAVE ANY LIABILITY FOR ANY DIRECT, SPECIAL,
|
272 |
+
INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES,
|
273 |
+
OR DAMAGES ARISING OUT OF THIS AGREEMENT OR YOUR USE OF THE LICENSED MATERIALS OR OTHER
|
274 |
+
EXERCISE OF YOUR RIGHTS UNDER THIS AGREEMENT, INCLUDING YOUR DEVELOPMENT OF ANY
|
275 |
+
DERIVATIVE TECHNOLOGY. THE FOREGOING LIMITATION WILL APPLY WHETHER SUCH LOSSES, COSTS,
|
276 |
+
EXPENSES, OR DAMAGES ARISE OUT OF BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE), OR
|
277 |
+
|
278 |
+
|
279 |
+
|
280 |
+
|
281 |
+
OTHERWISE AND REGARDLESS OF WHETHER SUCH DAMAGES WERE FORESEEABLE OR WE WERE
|
282 |
+
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS LIMITATION OF LIABILITY WILL BE INTERPRETED
|
283 |
+
IN A MANNER THAT, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, MOST CLOSELY
|
284 |
+
APPROXIMATES AN ABSOLUTE WAIVER OF ALL LIABILITY.
|
285 |
+
14. INDEMNIFICATION.
|
286 |
+
You agree to indemnify, defend, and hold harmless Us, Our affiliates, and Our and their
|
287 |
+
respective officers, directors, employees, partners, licensors, agents, successors, and assigns from and
|
288 |
+
against any and all losses, damages, liabilities, deficiencies, claims, actions, judgments, settlements,
|
289 |
+
interest, awards, penalties, fines, costs, or expenses of whatever kind, including reasonable attorneys’
|
290 |
+
fees, arising from or relating to Your use of the Licensed Materials or other exercise of Your rights under
|
291 |
+
this Agreement (including Your development of any Derivative Technology), Your access to or use of any
|
292 |
+
Third-Party Material, Your breach of any term of this Agreement, or Your violation of any law or right of a
|
293 |
+
third party (including any Intellectual Property Rights of a third party).
|
294 |
+
15. GENERAL PROVISIONS.
|
295 |
+
US Government Rights. The Licensed Materials include commercial computer software, as such
|
296 |
+
term is defined in 48 C.F.R. §2.101. Accordingly, if You are an agency of the US Government or any
|
297 |
+
contractor therefore, You receive only those rights with respect to the Licensed Materials as are granted
|
298 |
+
to all other end users under license, in accordance with (a) 48 C.F.R. §227.7201 through 48 C.F.R.
|
299 |
+
§227.7204, with respect to the Department of Defense and their contractors, or (b) 48 C.F.R. §12.212,
|
300 |
+
with respect to all other US Government licensees and their contractors.
|
301 |
+
Export Regulation. The Licensed Material or Derivative Technology may be subject to US export
|
302 |
+
control laws, including the Export Control Reform Act and its associated regulations. You will not,
|
303 |
+
directly or indirectly, export, re-export, or release the Licensed Material or any Derivative Technology to,
|
304 |
+
or make the Licensed Material or any Derivative Technology accessible from, any jurisdiction or country
|
305 |
+
to which export, re-export, or release is prohibited by law, rule, or regulation. You will comply with all
|
306 |
+
applicable federal laws, regulations, and rules, and complete all required undertakings (including
|
307 |
+
obtaining any necessary export license or other governmental approval), prior to exporting, re-exporting,
|
308 |
+
releasing, or otherwise making the Licensed Material or any Derivative Technology available outside the
|
309 |
+
United States.
|
310 |
+
Assignment. You may not assign this Agreement or any of your rights or obligations hereunder
|
311 |
+
without Our prior written consent and any attempt to do so without such consent will cause this
|
312 |
+
Agreement and any of Your rights hereunder to be null and void. We may assign this Agreement or any
|
313 |
+
of Our rights or obligations hereunder without Your consent.
|
314 |
+
Governing Law; Venue. This Agreement will be governed by and construed in accordance with
|
315 |
+
the laws of the State of Utah, United States, without giving effect to any choice of law provision or rule
|
316 |
+
that would cause the application of laws of any other jurisdiction and without regard to the United
|
317 |
+
Nations Convention on Contracts for the International Sale of Goods. You irrevocably agree that the
|
318 |
+
state and federal courts in the County of Salt Lake, Utah, United States, will have exclusive jurisdiction to
|
319 |
+
settle any dispute or claim arising out of or in connection with this Agreement, submit to the jurisdiction
|
320 |
+
of such courts, and consent to venue in such forum with respect to any action or proceeding that relates
|
321 |
+
to this Agreement. If We are the prevailing party in any action to enforce this Agreement, then We will
|
322 |
+
be entitled to recover Our reasonable costs and expenses in connection with such action, including
|
323 |
+
reasonable attorneys’ fees.
|
324 |
+
|
325 |
+
|
326 |
+
|
327 |
+
|
328 |
+
|
329 |
+
Equitable Relief. You acknowledge and agree that the restrictions set forth in this Agreement
|
330 |
+
are reasonable and necessary to protect Our legitimate interests, and that We would not have entered
|
331 |
+
into this Agreement in the absence of such restrictions, and that any breach or threatened breach by You
|
332 |
+
of any provision of this Agreement will result in irreparable injury to Us, for which there will be no
|
333 |
+
adequate remedy at law. In the event of any breach or threatened breach by You of any provision of this
|
334 |
+
Agreement, We will be authorized and entitled to obtain from any court of competent jurisdiction
|
335 |
+
injunctive relief, whether preliminary or permanent, specific performance, and an equitable accounting
|
336 |
+
of all earnings, profits, and other benefits arising from such breach, which rights will be cumulative and
|
337 |
+
in addition to any other rights or remedies to which We may be entitled at law or in equity. You waive
|
338 |
+
any requirement that We post a bond or other security as a condition for obtaining any such relief, or
|
339 |
+
show irreparable harm, balancing of harms, consideration of the public interest, or inadequacy of
|
340 |
+
monetary damages as a remedy.
|
341 |
+
Section Titles. The section titles and headers are for convenience or reference only and in no
|
342 |
+
way define, limit, or affect the scope or substance of any section of this Agreement.
|
343 |
+
Entire Agreement. Other than the Privacy Policy and any commercial agreement that You have
|
344 |
+
executed with Us in relation to the Licensed Materials, this Agreement constitutes the entire agreement
|
345 |
+
between You and Us with respect to the Licensed Materials.
|
346 |
+
Severability. If any provision of this Agreement is held to be unenforceable for any reason, then
|
347 |
+
such provision will be reformed only to the extent necessary to make it enforceable, and such holding
|
348 |
+
will not impair the validity, legality, or enforceability of the remaining provisions.
|
349 |
+
Waiver. No delay or omission by Us in exercising any right under this Agreement will operate as
|
350 |
+
a waiver of that or any other right. A waiver or consent given by Us on any one occasion will be effective
|
351 |
+
only in that instance and will not be construed as a bar or waiver of any right on any other occasion.
|
352 |
+
English Language. This Agreement is in the English language only, which language will be
|
353 |
+
controlling and any revision of this Agreement in any other language will not be binding.
|
354 |
+
Questions, Comments, and Concerns. All requests for technical support, and other
|
355 |
+
communications relating to the Licensed Materials or the subject matter of this Agreement, including
|
356 |
+
questions, inquiries, and concerns, should be directed to info@rxrx.ai.
|
357 |
+
|
358 |
+
|
359 |
+
|
360 |
+
|
361 |
+
|
362 |
+
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|